Indian Patents. 264887:"PROCESS FOR THE PREPERATION OF BENZENAMIDE COMPOUND"

Title of Invention	"PROCESS FOR THE PREPERATION OF BENZENAMIDE COMPOUND"
Abstract	The present invention provides a new method of making compounds of formula (I): wherein Rl is mono- or polysubstituted aryl; R2 is hydrogen, lower alkyl oraryl; and R4 is hydrogen, lower alkyl or halogen.

Full Text	PROCESS FOR THE SYNTHESIS OF ORGANIC COMPOUNDS Background of the Invention The present invention provides a new method of making compounds of formula (I): (Formula Removed) wherein R1 is mono- or polysubstituted aryl; R2 is hydrogen, lower alkyl or aryl; and R4 is hydrogen, lower alkyl, or halogen. Compounds of formula (I) have been disclosed in W. Breitenstein et al., WO 04/005281 which published on January 15,2004, the disclosure of which is incorporated by reference. A preferred compound of formula (I) is 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide (la). Compounds of formula (I) have been shown to inhibit one or more tyrosine kinases, such as c-Abl, Bcr-Abl, the receptor tyrosine kinases PDGF-R, Flt3, VEGF-R, EGF-R and c-Kit. As such, compounds of formula (I) can be used for the treatment of certain neoplastic diseases, such as leukemia. Previous synthesis of compounds of formula (I), and specifically (la), involves a hydrolysis of an ethyl ester to a carboxylic acid, which is then reacted with an aniline, and employing diethylcyanophosphonate as a coupling agent as shown in Scheme 1. Scheme 1 (Scheme Removed) This process gives low and inconsistent yields. Furthermore, diethylcyanophosphonate is an expensive reagent. Thus, there is a need for an alternate process that is cheaper, consistent, efficient, and produces compounds (I) in high yields. It is an object of this invention to provide for an alternative process to make compounds of formula (I) efficiently with high and consistent yields. It is a further object of this invention to make compounds of formula (I) from lower cost reagents. It is a still further object of this invention to provide for a process to make compounds of formula (I) utilizing safer reagents. The present invention overcomes the problems encountered in the previous synthesis described in Scheme 1 and typically resulted in an increased overall yield from 54-86%. Summary of the Invention The present invention provides a new method of making compounds of formula (I): (Formula Removed) comprising the following reaction: Scheme 2 (Scheme Removed) wherein R1 is substituted or unsubstituted aryl; R2 is hydrogen, lower alky or aryl; R4 is hydrogen, lower alkyl or halogen; and R3 is lower alkyl, phenyl, phenyl-lower alkyl or substituted phenyl. Direct condensation of ester (II) with aniline (IV) is catalyzed by a base, such as potassium tert-butoxide to make compounds of formula (I). The process is carried out at temperature between -50°C to 50°C in an organic solvent of tetrahydrofuran, dlmethylformamide, toluene or N-methylpyrrolidinone. Detailed Description of the Invention The general reaction scheme of the invention can be illustrated as follows: Scheme 2 (Scheme Removed) wherein R1 is substituted or unsubstituted aryl; R2 is hydrogen, lower alky or aryl; R4 is hydrogen, lower alkyl or halogen; and R3 is lower alkyl, phenyl, phenyl-lower alkyl or substituted phenyl. Direct condensation of ester (II) with aniline (IV) can be catalyzed by a strong base such as potassium tert-butoxide to make compounds of formula (I) in good yield and high purity without any chromatography or recrystallization purification. Other bases, such as metal hydride, bulkyl alkyl lithium, metal alkoxide, metal bis(trimethylsilyl) amide or lithium dialkylamide, can also be used. The metal can be lithium, sodium or potassium. The process is carried out at temperature between -50°C to 50°C in an organic solvent of tetrahydrofuran, dimethylformamide, toluene or N-methylpyrrolidinone. In a preferred embodiment, the process comprises the following reaction: Scheme 3 (Scheme Removed) wherein R3 is lower alkyl, phenyl, phenyl-lower alkyl or substituted phenyl. The compound of formula (IVa) can be prepared using processes disclosed in patent applications U.S. SN 60/688,920 and SN 60/688,976, both entitled "Process for the Synthesis of Organic Compounds", which were filed concurrently herewith. The disclosures of those applications are incorporated herein by reference. In the most preferred embodiment, the process comprises the following reaction: Scheme 4 (Scheme Removed) As used in this application, except as otherwise expressly provided herein, each of the following terms shall have the meaning set forth below. Lower alkyl comprises 1-6 carbon atoms, and is linear or branched; preferred lower alkyl moieties are butyl, such as n-butyl, seobutyl, isobutyl, tert-butyl, propyl, such as n-propyl or isopropyl, ethyl or methyl. Particularly preferred lower alkyl moieties are methyl, ethyl, n-propyl or tert-butyl. An aryl group is an aromatic radical which is bound to the molecule via a bond located at an aromatic ring carbon atom of the radical. In a preferred embodiment, aryl is an aromatic radical having 6-14 carbon atoms, especially phenyl, naphthyl, tetrahydronaphthyl, fluorenyl or phenanthrenyl, and is unsubstituted or substituted by one or more, preferably up to three, especially one or two substituents, wherein the substituents are heterocyclyl groups comprising one, two, three ring nitrogen atoms, one oxygen atom or one sulfur atom; other substituents on aryl include disubstituted amino, halogen, lower alkyl, substituted lower alkyl, tower alkenyl, lower alkynyl, phenyl, etherified hydroxy, esterified hydroxy, nitro, cyano, carboxy, esterified carboxy, alkanoyl, benzoyl, carbamoyl, N-mono- or A/,/V-disubstituted carbamoyl, amidino, guanidino, ureido, mercapto, sulfo, lower alkylthio, phenylthio, phenyl-lower alkylthio, lower alkylphenylthio, lower alkylsulfinyl, phenylsulfinyl, phenyl-lower alkylsulfinyl, lower alkylphenylsulfinyl, lower alkylsulfonyl, phenylsulfonyl, phenyl-lower alkylsulfonyl, lower alkylphenylsulfonyl, halogen-lower alkylmercapto, halogen-lower alkylsulfonyl, such as especially trifluoromethanesulfonyl, heterocyclyl, a mono- or bicyclic heteroaryl group or lower aikylene dioxy bound at adjacent C-atoms of the ring, such as methylene dioxy. According to a preferred embodiment, aryl is phenyl, naphthyl or tetrahydronaphthyl, which in each case is either unsubstituted or independently substituted by one or two substituents selected from the group consisting of halogen, especially fluorine, chlorine or bromine; hydroxy etherified by lower alkyl, e.g., by methyl, by halogen-lower alkyl, e.g., trifluoromethyl, or by phenyl; lower aikylene dioxy bound to two adjacent C-atoms, e.g., methylenedioxy, lower alkyl, e.g., methyl or propyl; halogen-lower alkyl, e.g., trifluoromethyl; hydroxy-lower alkyl, e.g., hydroxymethyl or 2-hydroxy-2-propyl; lower alkoxy-lower alkyl; e.g., methoxymethyl or 2-methoxyethyl; lower alkoxycarbonyl-lower alkyl, e.g., methoxy-carbonylmethyl; lower alkynyl, such as 1-propynyl; esterified carboxy, especially lower alkoxycarbonyl, e.g., methoxycarbonyl, n-propoxy carbonyl or isopropoxy carbonyl; AAmono-substituted carbamoyl, in particular, carbamoyl monosubstituted by lower alkyl, e.g., methyl, /i-propyl or isopropyl; di-lower alkylamino, e.g., dimethylamino or diethylamino; lower alkylene-amino, e.g., pyrrolidino or piperidino; lower oxaalkylene-amino, e.g., morpholino, lower azaalkylene-amino, e.g., piperazino, acylamino, e.g., acetylamino or benzoylamino; lower alkylsulfonyi, e.g., methylsulfonyl; sulfamoyl; and phenylsulfonyl. Halogen is fluorine, chlorine, bromine, or iodine, especially fluorine, chlorine, or bromine. The following examples more particularly illustrate the present invention, but do not limit the invention in any way. Example 1 Synthesis of compound of formula (la) (Formula Removed) To a 1-L flask, equipped with a mechanical stirrer, temperature sensor, reflux condenser, addition funnel and nitrogen inlet-outlet under a nitrogen atmosphere at 23°C is charged with compounds (l1e) (16 g), (IVa) (12 g) and THF (300 ml). The mixture is stirred for 15 minutes at 23°C and cooled to -20°C to -15°C. A solution of 1 M potassium f-butoxide • in THF (275 ml) is added at -20°C to -10°C. After the addition, the mixture is warmed to 18-23°C. When the reaction is complete according to HPLC, the mixture is cooled to 5°C. A solution of 15% aqueous sodium chloride (500 mL) is added to the mixture, maintaining temperature below 15°C. Product is extracted into isopropyl acetate (500 mL) and washed in sequence with 15% aqueous sodium chloride solution (500 mL) and water (500 mL). The organic phase is distilled under atmospheric pressure at an internal temperature of 75-85°C until the residual volume is about 200 mL The resulting suspension is cooled to 70 ± 5°C and charged with ethanol (250 mL) and water (30 mL). The mixture is heated to reflux (78CC) for 1 hour and then cooled to -10°C to -15°C. The suspension is stirred for an additional 30 minutes at -10°C to -15°C. Any solid is collected by filtration, rinsed with cold (5°C) ethanol (85 mL) and dried under vacuum (10-20 torr) at 55-60°C with a nitrogen bleed (8-16 hours) to obtain AMN107 (17.4 g, 67% yield) as a white solid. 1H NMR 300 MHz, DMSO-d6), δ10.5 (s, 1H), 9.15 (s, 1H), 9.05 (S, 1H), 8.60 (s, 1H), 8.45 (d, 1H), 8.35 (d, 1H), 8.22 (d, 2H), 8.10 (d, 2H), 7.65 (m, 2H), 7.45 (m, 4H), 2.25 (s, 3H), 2.05 (S, 3H). What is claimed is: 1. A process for the preparation of compounds of formula (I) (Formula Removed) comprising reacting the compound: (Formula Removed) with R1-NH-R2, wherein R1 is substituted or unsubstituted aryl; R2 is hydrogen, lower alky or aryl; R4 is hydrogen, lower alkyl or halogen; and R3 is lower alkyl, phenyl, phenyl-lower alkyl or substituted phenyl, and wherein the process is catalyzed by a base in an organic solvent. 2. A process for the preparation of a compound of the formula (la) (Formula Removed) comprising reacting the compound: (Formula Removed) wherein R3 is lower alkyl, phenyl, phenyl-lower alkyl or substituted phenyl, with the compound 5-(4-methyl-1 W-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine of the structure (IVa): (Formula Removed) and wherein the process is catalyzed by a base in an organic solvent. 3. A process for the preparation of a compound of the formula (la) (Formula Removed) comprising reacting the compound: (Formula Removed) with 5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine (IVa) wherein the process is catalyzed by a base in an organic solvent. 4. The process of any one of Claims 1 -3, wherein the base is selected from the group consisting of metal hydride, bulky alkyl lithium, metal alkoxide, metal bis(trimethylsilyl)amide and lithium dialkylamide. t 5. The process of Claim 4, wherein the metal is selected from the group consisting of lithium, sodium and potassium. 6. The process of Claim 4, wherein the base is potassium fert-butoxide. 7. The process of any one of Claims 1-3, wherein the organic solvent is selected from the group of tetrahydrofuran, dimethylformamide, toluene and N-methylpyrrolidone.

Full Text

PROCESS FOR THE SYNTHESIS OF ORGANIC COMPOUNDS
Background of the Invention
The present invention provides a new method of making compounds of formula (I):

(Formula Removed)
wherein
R1 is mono- or polysubstituted aryl; R2 is hydrogen, lower alkyl or aryl; and R4 is hydrogen, lower alkyl, or halogen.
Compounds of formula (I) have been disclosed in W. Breitenstein et al., WO 04/005281 which published on January 15,2004, the disclosure of which is incorporated by reference. A preferred compound of formula (I) is 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide (la). Compounds of formula (I) have been shown to inhibit one or more tyrosine kinases, such as c-Abl, Bcr-Abl, the receptor tyrosine kinases PDGF-R, Flt3, VEGF-R, EGF-R and c-Kit. As such, compounds of formula (I) can be used for the treatment of certain neoplastic diseases, such as leukemia.
Previous synthesis of compounds of formula (I), and specifically (la), involves a hydrolysis of an ethyl ester to a carboxylic acid, which is then reacted with an aniline, and employing diethylcyanophosphonate as a coupling agent as shown in Scheme 1.
Scheme 1

(Scheme Removed)

This process gives low and inconsistent yields. Furthermore,
diethylcyanophosphonate is an expensive reagent. Thus, there is a need for an alternate process that is cheaper, consistent, efficient, and produces compounds (I) in high yields.
It is an object of this invention to provide for an alternative process to make compounds of formula (I) efficiently with high and consistent yields.
It is a further object of this invention to make compounds of formula (I) from lower cost reagents.
It is a still further object of this invention to provide for a process to make compounds of formula (I) utilizing safer reagents.
The present invention overcomes the problems encountered in the previous synthesis
described in Scheme 1 and typically resulted in an increased overall yield from 54-86%.
Summary of the Invention
The present invention provides a new method of making compounds of formula (I):
(Formula Removed)
comprising the following reaction:
Scheme 2
(Scheme Removed)
wherein
R1 is substituted or unsubstituted aryl;
R2 is hydrogen, lower alky or aryl;
R4 is hydrogen, lower alkyl or halogen; and
R3 is lower alkyl, phenyl, phenyl-lower alkyl or substituted phenyl.
Direct condensation of ester (II) with aniline (IV) is catalyzed by a base, such as potassium tert-butoxide to make compounds of formula (I). The process is carried out at temperature between -50°C to 50°C in an organic solvent of tetrahydrofuran, dlmethylformamide, toluene or N-methylpyrrolidinone.
Detailed Description of the Invention
The general reaction scheme of the invention can be illustrated as follows:
Scheme 2
(Scheme Removed)
wherein
R1 is substituted or unsubstituted aryl;
R2 is hydrogen, lower alky or aryl;
R4 is hydrogen, lower alkyl or halogen; and
R3 is lower alkyl, phenyl, phenyl-lower alkyl or substituted phenyl.
Direct condensation of ester (II) with aniline (IV) can be catalyzed by a strong base such as potassium tert-butoxide to make compounds of formula (I) in good yield and high purity without any chromatography or recrystallization purification. Other bases, such as metal hydride, bulkyl alkyl lithium, metal alkoxide, metal bis(trimethylsilyl) amide or lithium dialkylamide, can also be used. The metal can be lithium, sodium or potassium. The process is carried out at temperature between -50°C to 50°C in an organic solvent of tetrahydrofuran, dimethylformamide, toluene or N-methylpyrrolidinone.
In a preferred embodiment, the process comprises the following reaction:
Scheme 3

(Scheme Removed)

wherein R3 is lower alkyl, phenyl, phenyl-lower alkyl or substituted phenyl.
The compound of formula (IVa) can be prepared using processes disclosed in patent applications U.S. SN 60/688,920 and SN 60/688,976, both entitled "Process for the Synthesis of Organic Compounds", which were filed concurrently herewith. The disclosures of those applications are incorporated herein by reference.
In the most preferred embodiment, the process comprises the following reaction:
Scheme 4

(Scheme Removed)
As used in this application, except as otherwise expressly provided herein, each of the following terms shall have the meaning set forth below.
Lower alkyl comprises 1-6 carbon atoms, and is linear or branched; preferred lower alkyl moieties are butyl, such as n-butyl, seobutyl, isobutyl, tert-butyl, propyl, such as n-propyl or isopropyl, ethyl or methyl. Particularly preferred lower alkyl moieties are methyl, ethyl, n-propyl or tert-butyl.
An aryl group is an aromatic radical which is bound to the molecule via a bond located at an aromatic ring carbon atom of the radical. In a preferred embodiment, aryl is an aromatic radical having 6-14 carbon atoms, especially phenyl, naphthyl, tetrahydronaphthyl, fluorenyl or phenanthrenyl, and is unsubstituted or substituted by one or more, preferably up to three, especially one or two substituents, wherein the substituents are heterocyclyl groups
comprising one, two, three ring nitrogen atoms, one oxygen atom or one sulfur atom; other substituents on aryl include disubstituted amino, halogen, lower alkyl, substituted lower alkyl, tower alkenyl, lower alkynyl, phenyl, etherified hydroxy, esterified hydroxy, nitro, cyano, carboxy, esterified carboxy, alkanoyl, benzoyl, carbamoyl, N-mono- or A/,/V-disubstituted carbamoyl, amidino, guanidino, ureido, mercapto, sulfo, lower alkylthio, phenylthio, phenyl-lower alkylthio, lower alkylphenylthio, lower alkylsulfinyl, phenylsulfinyl, phenyl-lower alkylsulfinyl, lower alkylphenylsulfinyl, lower alkylsulfonyl, phenylsulfonyl, phenyl-lower alkylsulfonyl, lower alkylphenylsulfonyl, halogen-lower alkylmercapto, halogen-lower alkylsulfonyl, such as especially trifluoromethanesulfonyl, heterocyclyl, a mono- or bicyclic heteroaryl group or lower aikylene dioxy bound at adjacent C-atoms of the ring, such as methylene dioxy. According to a preferred embodiment, aryl is phenyl, naphthyl or tetrahydronaphthyl, which in each case is either unsubstituted or independently substituted by one or two substituents selected from the group consisting of halogen, especially fluorine, chlorine or bromine; hydroxy etherified by lower alkyl, e.g., by methyl, by halogen-lower alkyl, e.g., trifluoromethyl, or by phenyl; lower aikylene dioxy bound to two adjacent C-atoms, e.g., methylenedioxy, lower alkyl, e.g., methyl or propyl; halogen-lower alkyl, e.g., trifluoromethyl; hydroxy-lower alkyl, e.g., hydroxymethyl or 2-hydroxy-2-propyl; lower alkoxy-lower alkyl; e.g., methoxymethyl or 2-methoxyethyl; lower alkoxycarbonyl-lower alkyl, e.g., methoxy-carbonylmethyl; lower alkynyl, such as 1-propynyl; esterified carboxy, especially lower alkoxycarbonyl, e.g., methoxycarbonyl, n-propoxy carbonyl or isopropoxy carbonyl; AAmono-substituted carbamoyl, in particular, carbamoyl monosubstituted by lower alkyl, e.g., methyl, /i-propyl or isopropyl; di-lower alkylamino, e.g., dimethylamino or diethylamino; lower alkylene-amino, e.g., pyrrolidino or piperidino; lower oxaalkylene-amino, e.g., morpholino, lower azaalkylene-amino, e.g., piperazino, acylamino, e.g., acetylamino or benzoylamino; lower alkylsulfonyi, e.g., methylsulfonyl; sulfamoyl; and phenylsulfonyl.
Halogen is fluorine, chlorine, bromine, or iodine, especially fluorine, chlorine, or bromine.
The following examples more particularly illustrate the present invention, but do not limit the invention in any way.
Example 1
Synthesis of compound of formula (la)
(Formula Removed)
To a 1-L flask, equipped with a mechanical stirrer, temperature sensor, reflux condenser, addition funnel and nitrogen inlet-outlet under a nitrogen atmosphere at 23°C is charged with compounds (l1e) (16 g), (IVa) (12 g) and THF (300 ml). The mixture is stirred for 15 minutes at 23°C and cooled to -20°C to -15°C. A solution of 1 M potassium f-butoxide • in THF (275 ml) is added at -20°C to -10°C. After the addition, the mixture is warmed to 18-23°C. When the reaction is complete according to HPLC, the mixture is cooled to 5°C. A solution of 15% aqueous sodium chloride (500 mL) is added to the mixture, maintaining temperature below 15°C. Product is extracted into isopropyl acetate (500 mL) and washed in sequence with 15% aqueous sodium chloride solution (500 mL) and water (500 mL). The organic phase is distilled under atmospheric pressure at an internal temperature of 75-85°C until the residual volume is about 200 mL The resulting suspension is cooled to 70 ± 5°C and charged with ethanol (250 mL) and water (30 mL). The mixture is heated to reflux (78CC) for 1 hour and then cooled to -10°C to -15°C. The suspension is stirred for an
additional 30 minutes at -10°C to -15°C. Any solid is collected by filtration, rinsed with cold (5°C) ethanol (85 mL) and dried under vacuum (10-20 torr) at 55-60°C with a nitrogen bleed (8-16 hours) to obtain AMN107 (17.4 g, 67% yield) as a white solid.
1H NMR 300 MHz, DMSO-d6), δ10.5 (s, 1H), 9.15 (s, 1H), 9.05 (S, 1H), 8.60 (s, 1H), 8.45 (d, 1H), 8.35 (d, 1H), 8.22 (d, 2H), 8.10 (d, 2H), 7.65 (m, 2H), 7.45 (m, 4H), 2.25 (s, 3H), 2.05 (S, 3H).

What is claimed is:
1. A process for the preparation of compounds of formula (I)
(Formula Removed)
comprising reacting the compound:
(Formula Removed)
with R1-NH-R2, wherein
R1 is substituted or unsubstituted aryl;
R2 is hydrogen, lower alky or aryl;
R4 is hydrogen, lower alkyl or halogen; and
R3 is lower alkyl, phenyl, phenyl-lower alkyl or substituted phenyl, and wherein the process is catalyzed by a base in an organic solvent.
2. A process for the preparation of a compound of the formula (la)
(Formula Removed)
comprising reacting the compound:
(Formula Removed)
wherein R3 is lower alkyl, phenyl, phenyl-lower alkyl or substituted phenyl, with the compound 5-(4-methyl-1 W-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine of the structure (IVa):
(Formula Removed)
and wherein the process is catalyzed by a base in an organic solvent.
3. A process for the preparation of a compound of the formula (la)

(Formula Removed)

comprising reacting the compound:
(Formula Removed)
with 5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine (IVa) wherein the process is catalyzed by a base in an organic solvent.
4. The process of any one of Claims 1 -3, wherein the base is selected from the group
consisting of metal hydride, bulky alkyl lithium, metal alkoxide, metal bis(trimethylsilyl)amide
and lithium dialkylamide.
t
5. The process of Claim 4, wherein the metal is selected from the group consisting of
lithium, sodium and potassium.
6. The process of Claim 4, wherein the base is potassium fert-butoxide.
7. The process of any one of Claims 1-3, wherein the organic solvent is selected from
the group of tetrahydrofuran, dimethylformamide, toluene and N-methylpyrrolidone.

Documents:

8895-delnp-2007-Abstract-(06-06-2014).pdf

8895-delnp-2007-abstract.pdf

8895-delnp-2007-assignment.pdf

8895-delnp-2007-Claims-(06-06-2014).pdf

8895-delnp-2007-Claims-(07-01-2015).pdf

8895-delnp-2007-claims.pdf

8895-delnp-2007-Correspondence Others-(05-12-2014).pdf

8895-delnp-2007-Correspondence Others-(07-01-2015).pdf

8895-delnp-2007-Correspondence Others-(08-01-2015).pdf

8895-DELNP-2007-Correspondence-171214.pdf

8895-delnp-2007-Correspondence-Others-(06-06-2014).pdf

8895-delnp-2007-correspondence-others.pdf

8895-delnp-2007-Description (Complete)-(06-06-2014).pdf

8895-delnp-2007-description (complete).pdf

8895-delnp-2007-Form-1-(07-01-2015).pdf

8895-delnp-2007-form-1.pdf

8895-delnp-2007-Form-2-(06-06-2014).pdf

8895-delnp-2007-form-2.pdf

8895-delnp-2007-Form-3-(05-12-2014).pdf

8895-delnp-2007-Form-3-(06-06-2014).pdf

8895-delnp-2007-Form-3-(08-01-2015).pdf

8895-delnp-2007-form-3.pdf

8895-delnp-2007-form-5.pdf

8895-delnp-2007-GPA-(06-06-2014).pdf

8895-delnp-2007-Others-(08-01-2015).pdf

8895-delnp-2007-Others-(17-12-2014).pdf

8895-delnp-2007-pct-210.pdf

8895-delnp-2007-pct-220.pdf

8895-delnp-2007-pct-237.pdf

8895-delnp-2007-pct-311.pdf

petition_20140606110017.pdf

« Previous Patent

Next Patent »

Patent Number

264887

Indian Patent Application Number

8895/DELNP/2007

PG Journal Number

05/2015

Publication Date

30-Jan-2015

Grant Date

28-Jan-2015

Date of Filing

19-Nov-2007

Name of Patentee

NOVARTIS AG.,

Applicant Address

LICHTSTRASSE 35, CH-4056 BASEL SWITZERLAND.

Inventors:

#	Inventor's Name	Inventor's Address
1	SHIEH WEN-CHUNG	295 TIMBER DRIVE BERKELEY HEIGHTS, NEW JERSEY 07922 USA.
2	MCKENNA JOSEPH,	1237 SEIFERT ROAD, NAZARETH, PENNSYLVANIA 18064 USA.

PCT International Classification Number

C07D 401/07

PCT International Application Number

PCT/US2006/022155

PCT International Filing date

2006-06-07

PCT Conventions:

#	PCT Application Number	Date of Convention	Priority Country
1	60/705,590	2005-08-04	U.S.A.
2	60/688,977	2005-06-09	U.S.A.